{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T10:06:45Z","timestamp":1780308405175,"version":"3.54.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5P50 CA098258-13"],"award-info":[{"award-number":["5P50 CA098258-13"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijgc.2026.104698","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T08:31:35Z","timestamp":1775896295000},"page":"104698","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Androgen receptor as a therapeutic target in endometrial cancer: a narrative review"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1655-6877","authenticated-orcid":false,"given":"Hadi","family":"Erfani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Martynova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5725-9994","authenticated-orcid":false,"given":"Shinya","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6232-8701","authenticated-orcid":false,"given":"Koji","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6960-4414","authenticated-orcid":false,"given":"Lynda D.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil K.","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3205-0128","authenticated-orcid":false,"given":"Katherine C.","family":"Kurnit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1922-0156","authenticated-orcid":false,"given":"Shannon N.","family":"Westin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijgc.2026.104698_bib1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104698_bib2","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"21","key":"10.1016\/j.ijgc.2026.104698_bib3","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMra1514010","article-title":"Endometrial cancer","volume":"383","author":"Lu","year":"2020","journal-title":"N Engl J Med."},{"issue":"3","key":"10.1016\/j.ijgc.2026.104698_bib4","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/AOG.0000000000004676","article-title":"The changing landscape of gynecologic cancer mortality in the United States","volume":"139","author":"Giaquinto","year":"2022","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104698_bib5","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqad071","article-title":"Stranger things: new roles and opportunities for androgen receptor in oncology beyond prostate cancer","volume":"164","author":"Leo","year":"2023","journal-title":"Endocrinology"},{"issue":"13","key":"10.1016\/j.ijgc.2026.104698_bib6","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/cncr.28695","article-title":"The 2014 Surgeon General\u2018s report: \u201cThe health consequences of smoking\u201450 years of progress\u201d: a paradigm shift in cancer care","volume":"120","author":"Warren","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.ijgc.2026.104698_bib7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.canlet.2018.09.001","article-title":"Regulation of sex hormone receptors in sexual dimorphism of human cancers","volume":"438","author":"Zheng","year":"2018","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104698_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-019-0060-9","article-title":"Kaposi sarcoma","volume":"5","author":"Cesarman","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"10.1016\/j.ijgc.2026.104698_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009947","article-title":"Androgen receptor transactivates KSHV noncoding RNA PAN to promote lytic replication\u2013mediated oncogenesis: a mechanism of sex disparity in KS","volume":"17","author":"Ding","year":"2021","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijgc.2026.104698_bib10","doi-asserted-by":"crossref","first-page":"206","DOI":"10.11604\/pamj.2020.37.206.26175","article-title":"Kaposi\u2018s sarcoma of the larynx: an unusual location in an HIV-negative patient (a case report)","volume":"37","author":"Naimi","year":"2020","journal-title":"Pan Afr Med J"},{"issue":"15","key":"10.1016\/j.ijgc.2026.104698_bib11","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1158\/0008-5472.CAN-13-0930","article-title":"Progesterone receptor signaling in the microenvironment of endometrial cancer influences its response to hormonal therapy","volume":"73","author":"Janzen","year":"2013","journal-title":"Cancer Res"},{"issue":"7630","key":"10.1016\/j.ijgc.2026.104698_bib12","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1136\/bmj.39367.495995.AE","article-title":"Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study","volume":"335","author":"Reeves","year":"2007","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104698_bib13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1158\/1055-9965.EPI-14-0923","article-title":"Metabolic syndrome and risk of endometrial cancer in the United States: a study in the SEER-medicare linked database","volume":"24","author":"Trabert","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"10.1016\/j.ijgc.2026.104698_bib14","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1210\/jcem-59-5-949","article-title":"Elevated production and metabolic clearance rates of androgens in morbidly obese women","volume":"59","author":"Samojlik","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104698_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/1098-2744(200010)29:2<59::AID-MC2>3.0.CO;2-6","article-title":"Inactivation of the human androgen receptor gene is associated with CpG hypermethylation in uterine endometrial cancer","volume":"29","author":"Sasaki","year":"2000","journal-title":"Mol Carcinog"},{"issue":"5","key":"10.1016\/j.ijgc.2026.104698_bib16","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/ijc.10394","article-title":"Expression of androgen receptor and 5\u03b1-reductases in the human normal endometrium and its disorders","volume":"99","author":"Ito","year":"2002","journal-title":"Int J Cancer"},{"issue":"31","key":"10.1016\/j.ijgc.2026.104698_bib17","doi-asserted-by":"crossref","first-page":"49289","DOI":"10.18632\/oncotarget.10334","article-title":"Androgen receptor as potential therapeutic target in metastatic endometrial cancer","volume":"7","author":"Tangen","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104698_bib18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s13104-018-3403-9","article-title":"Androgen receptor expression in endometrial carcinoma and its correlation with clinicopathologic features","volume":"11","author":"Hashmi","year":"2018","journal-title":"BMC Res Notes"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104698_bib19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/PGP.0000000000000401","article-title":"Androgen receptor expression in endometrial carcinoma","volume":"37","author":"Zadeh","year":"2018","journal-title":"Int J Gynecol Pathol"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104698_bib20","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/bjc.2016.16","article-title":"Androgen receptors are acquired by healthy postmenopausal endometrial epithelium and their subsequent loss in endometrial cancer is associated with poor survival","volume":"114","author":"Kamal","year":"2016","journal-title":"Br J Cancer"},{"issue":"7","key":"10.1016\/j.ijgc.2026.104698_bib21","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/1097-0142(19861001)58:7<1506::AID-CNCR2820580722>3.0.CO;2-6","article-title":"Correlation of female sex steroid hormone receptors with histologic and ultrastructural differentiation in adenocarcinoma of the endometrium","volume":"58","author":"Geisinger","year":"1986","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104698_bib22","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.canlet.2005.08.001","article-title":"Steroid receptor expressions in endometrial cancer: clinical significance and epidemiological implication","volume":"239","author":"Jeon","year":"2006","journal-title":"Cancer Lett"},{"issue":"5","key":"10.1016\/j.ijgc.2026.104698_bib23","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1158\/0008-5472.CAN-06-4123","article-title":"Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women","volume":"67","author":"Haiman","year":"2007","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.ijgc.2026.104698_bib24","first-page":"3955","article-title":"A polymorphism in CYP17 and endometrial cancer risk","volume":"61","author":"Haiman","year":"2001","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104698_bib25","first-page":"627","article-title":"Estrogen receptor beta (ESR2) polymorphisms and endometrial cancer (United States)","volume":"15","author":"Setiawan","year":"2004","journal-title":"Cancer Causes Control"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104698_bib26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1158\/1055-9965.EPI-03-0241","article-title":"HSD17B1 gene polymorphisms and risk of endometrial and breast cancer","volume":"13","author":"Setiawan","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104698_bib27","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1158\/1055-9965.EPI-08-0689","article-title":"Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the epidemiology of endometrial cancer consortium","volume":"18","author":"Setiawan","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"10.1016\/j.ijgc.2026.104698_bib28","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/carcin\/bgp328","article-title":"Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes","volume":"31","author":"Yang","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ijgc.2026.104698_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2021.462228","article-title":"A quantitative analysis of total and free 11-oxygenated androgens and its application to human serum and plasma specimens using liquid-chromatography tandem mass spectrometry","volume":"1650","author":"Caron","year":"2021","journal-title":"J Chromatogr A"},{"issue":"5-6","key":"10.1016\/j.ijgc.2026.104698_bib30","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0039-128X(98)00007-5","article-title":"DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging","volume":"63","author":"Labrie","year":"1998","journal-title":"Steroids"},{"issue":"7447","key":"10.1016\/j.ijgc.2026.104698_bib31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104698_bib32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0300-595X(86)80021-4","article-title":"Adrenal and gonadal androgen secretion in normal females","volume":"15","author":"Longcope","year":"1986","journal-title":"Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104698_bib33","doi-asserted-by":"crossref","first-page":"T203","DOI":"10.1530\/ERC-13-0551","article-title":"Evidence of androgen action in endometrial and ovarian cancers","volume":"21","author":"Gibson","year":"2014","journal-title":"Endocr-Relat Cancer."},{"issue":"4","key":"10.1016\/j.ijgc.2026.104698_bib34","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00404-017-4295-y","article-title":"Effects of a hyperandrogenaemic state on the proliferation and decidualization potential in human endometrial stromal cells","volume":"295","author":"Freis","year":"2017","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104698_bib35","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0015-0282(00)00711-1","article-title":"Do androgens have a direct effect on endometrial function? An in vitro study","volume":"74","author":"Tuckerman","year":"2000","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104698_bib36","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/gme.0b013e318148bb99","article-title":"Effects of testosterone and estrogen treatment on the distribution of sex hormone receptors in the endometrium of postmenopausal women","volume":"15","author":"Zang","year":"2008","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104698_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-55291-8","article-title":"Synergistic effects of hyperandrogenemia and obesogenic western-style diet on transcription and DNA methylation in visceral adipose tissue of nonhuman primates","volume":"9","author":"Carbone","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104698_bib38","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/ajcn\/45.1.277","article-title":"Adipose tissue as a source of hormones","volume":"45","author":"Siiteri","year":"1987","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104698_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.17077\/2154-4751.1098","article-title":"Hormones and receptors in endometrial cancer","volume":"2","author":"Bender","year":"2011","journal-title":"Proc Obstet Gynecol"},{"issue":"17","key":"10.1016\/j.ijgc.2026.104698_bib40","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1016\/j.ejca.2014.09.003","article-title":"Loss of progesterone receptor links to high proliferation and increases from primary to metastatic endometrial cancer lesions","volume":"50","author":"Tangen","year":"2014","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.ijgc.2026.104698_bib41","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1158\/1078-0432.CCR-12-3039","article-title":"Lack of estrogen receptor-\u03b1 is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma","volume":"19","author":"Wik","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104698_bib42","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1517\/13543784.10.3.493","article-title":"Hormonal treatment for prostate cancer","volume":"10","author":"Harris","year":"2001","journal-title":"Expert Opin Investig Drugs"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104698_bib43","doi-asserted-by":"crossref","first-page":"R257","DOI":"10.1530\/JME-14-0030","article-title":"Revising the role of the androgen receptor in breast cancer","volume":"52","author":"Fioretti","year":"2014","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.ijgc.2026.104698_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.729498","article-title":"The role of androgen receptor in cross talk between stromal cells and prostate cancer epithelial cells","volume":"9","author":"Tang","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104698_bib45","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/aja.2008.39","article-title":"Stroma-epithelium crosstalk in prostate cancer","volume":"11","author":"Niu","year":"2009","journal-title":"Asian J Androl"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104698_bib46","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13045-019-0770-1","article-title":"Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy","volume":"12","author":"Liu","year":"2019","journal-title":"J Hematol Oncol"},{"issue":"13","key":"10.1016\/j.ijgc.2026.104698_bib47","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1016\/j.celrep.2018.12.015","article-title":"Dissecting effects of anti-cancer drugs and cancer-associated fibroblasts by on-chip reconstitution of immunocompetent tumor microenvironments","volume":"25","author":"Nguyen","year":"2018","journal-title":"Cell Rep"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104698_bib48","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.cell.2008.01.018","article-title":"FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription","volume":"132","author":"Lupien","year":"2008","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ijgc.2026.104698_bib49","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.semcancer.2004.04.010","article-title":"Notch signaling and cancer: emerging complexity","volume":"14","author":"Axelson","year":"2004","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104698_bib50","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/IGC.0b013e3181a12ed2","article-title":"Notch signaling pathway in ovarian cancer","volume":"19","author":"Rose","year":"2009","journal-title":"Int J Gynecol Cancer"},{"issue":"12","key":"10.1016\/j.ijgc.2026.104698_bib51","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1093\/carcin\/bgp236","article-title":"Role of notch signaling in colorectal cancer","volume":"30","author":"Qiao","year":"2009","journal-title":"Carcinogenesis"},{"issue":"15","key":"10.1016\/j.ijgc.2026.104698_bib52","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1038\/emboj.2011.216","article-title":"Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1","volume":"30","author":"Robinson","year":"2011","journal-title":"EMBO J"},{"issue":"19","key":"10.1016\/j.ijgc.2026.104698_bib53","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1038\/emboj.2011.328","article-title":"Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer","volume":"30","author":"Sahu","year":"2011","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.ijgc.2026.104698_bib54","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1471-2407-14-78","article-title":"FOXA1 promotes tumor cell proliferation through AR involving the Notch pathway in endometrial cancer","volume":"14","author":"Qiu","year":"2014","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104698_bib55","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1186\/1471-2407-14-752","article-title":"Reversible inhibition of lysine specific demethylase 1 is a novel anti-tumor strategy for poorly differentiated endometrial carcinoma","volume":"14","author":"Theisen","year":"2014","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104698_bib56","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1139\/bcb-2012-0054","article-title":"The oncogenic potential of Jumonji D2 (JMJD2\/KDM4) histone demethylase overexpression","volume":"91","author":"Young","year":"2013","journal-title":"Biochem Cell Biol"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104698_bib57","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/ncb1546","article-title":"Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression","volume":"9","author":"Wissmann","year":"2007","journal-title":"Nat Cell Biol"},{"issue":"10","key":"10.1016\/j.ijgc.2026.104698_bib58","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1158\/0008-5472.CAN-12-4300","article-title":"KDM4\/JMJD2 histone demethylases: epigenetic regulators in cancer cells","volume":"73","author":"Berry","year":"2013","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104698_bib59","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.bbrc.2007.05.179","article-title":"Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D","volume":"359","author":"Shin","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"issue":"31","key":"10.1016\/j.ijgc.2026.104698_bib60","doi-asserted-by":"crossref","first-page":"31702","DOI":"10.18632\/oncotarget.5165","article-title":"KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27Kip1","volume":"6","author":"Qiu","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104698_bib61","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/PGP.0000000000000756","article-title":"Androgen receptor immunohistochemical expression in undifferentiated\/dedifferentiated endometrial carcinoma","volume":"41","author":"Cao","year":"2022","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ijgc.2026.104698_bib62","series-title":"Paper presented at: Society of Gynecologic Oncology 2021 Virtual Annual Meeting on Women\u2019s Cancer","article-title":"ENPAC: phase II study with safety lead-in of enzalutamide in combination with carboplatin and paclitaxel in advanced\/recurrent endometrioid endometrial cancer","author":"Westin","year":"2021"},{"key":"10.1016\/j.ijgc.2026.104698_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2024.07.035","article-title":"Molecular markers of response to enzalutamide-based therapy in advanced or recurrent endometrioid endometrial adenocarcinoma (ENPAC study)","volume":"190","author":"Sood","year":"2024","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104698_bib64","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"issue":"10","key":"10.1016\/j.ijgc.2026.104698_bib66","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/s41588-020-0681-7","article-title":"Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer","volume":"52","author":"Gao","year":"2020","journal-title":"Nat Genet."},{"issue":"10","key":"10.1016\/j.ijgc.2026.104698_bib67","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/s41588-020-0702-6","article-title":"Targeting LSD1 and FOXA1 in prostate cancer","volume":"52","author":"Omarjee","year":"2020","journal-title":"Nat Genet."},{"issue":"1","key":"10.1016\/j.ijgc.2026.104698_bib68","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/cas.16005","article-title":"KDM4B: A promising oncology therapeutic target","volume":"115","author":"Ni","year":"2024","journal-title":"Cancer Sci"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104698_bib69","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1096\/fj.201902584R","article-title":"Advances in histone demethylase KDM4 as cancer therapeutic targets","volume":"34","author":"Lee","year":"2020","journal-title":"FASEB J"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104698_bib70","doi-asserted-by":"crossref","first-page":"e608","DOI":"10.1002\/onco.13627","article-title":"Gamma secretase inhibitors in cancer: a current perspective on clinical performance","volume":"26","author":"McCaw","year":"2021","journal-title":"Oncologist"},{"issue":"10","key":"10.1016\/j.ijgc.2026.104698_bib71","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJMoa2210140","article-title":"Nirogacestat, a \u03b3-secretase inhibitor for desmoid tumors","volume":"388","author":"Gounder","year":"2023","journal-title":"N Engl J Med"},{"issue":"7915","key":"10.1016\/j.ijgc.2026.104698_bib72","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41586-022-04522-6","article-title":"Androgen receptor activity in T cells limits checkpoint blockade efficacy","volume":"606","author":"Guan","year":"2022","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104698_bib73","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.4049\/jimmunol.177.2.1062","article-title":"Epigenetic remodeling of the IL-2 and IFN-gamma loci in memory CD8 T cells is influenced by CD4 T cells","volume":"177","author":"Northrop","year":"2006","journal-title":"J Immunol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X2600229X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X2600229X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T09:35:07Z","timestamp":1780306507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X2600229X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":72,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1048891X2600229X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.104698","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Androgen receptor as a therapeutic target in endometrial cancer: a narrative review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.104698","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Society of Gynaecological Oncology and the International Gynecologic Cancer Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104698"}}